Position in PYXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$363,302
+$85,420 QoQ
Shares Held
248,837
+3.0% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 78 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 66.8642525026423.ToString("F0")%
Shared 0.ToString("F0")%
None 33.13574749735771.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. PYXS ranks #314 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in PYXS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $363,302 | 248,837 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $277,882 | 241,637 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $448,562 | 202,055 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $204,660 | 186,055 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $913,554 | 932,198 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,472,902 | 944,168 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,491,091 | 951,251 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,459,022 | 742,907 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $465,852 | 109,355 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $149,499 | 83,055 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $165,279 | 83,055 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $188,643 | 73,689 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $249,778 | 62,289 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $83,467 | 62,289 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $61,048 | 30,989 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $73,753 | 30,989 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $584,971 | 144,795 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,018,838 | 92,875 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||